Vascular protection by high-density lipoprotein-associated sphingosine-1-phosphate

被引:0
|
作者
Xi WANG
Fan WANG
机构
[1] DepartmentofGeriatricCardiology,ChinesePLAGeneralHospital
关键词
D O I
暂无
中图分类号
R54 [心脏、血管(循环系)疾病];
学科分类号
摘要
Epidemiological studies and animal experiments have consistently demonstrated cardiovascular protection by high-density lipoprotein(HDL). Findings from a growing number of studies further indicate that sphingosine-1-phosphate(SIP) mediates many of the beneficial effects of HDL on the cardiovascular system, including vasodilatation, angiogenesis, maintenance of endothelial barrier function, and protection against atherosclerosis and ischemia/reperfusion injury. In this review, we summarize the most recent literature investigating the effects of HDL-S1P on cardiovascular health and highlight potential opportunities for clinical translation of these findings.
引用
收藏
页码:696 / 702
页数:7
相关论文
共 50 条
  • [41] Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease
    van der Giet, Markus
    Toelle, Markus
    Kleuser, Burkhard
    BIOLOGICAL CHEMISTRY, 2008, 389 (11) : 1381 - 1390
  • [42] Broad and diverse roles of sphingosine-1-phosphate/sphingosine-1-phosphate receptors in the prostate
    Liu, Daoquan
    Liu, Jianmin
    Li, Yan
    Du, Lu
    Cao, Qingqiong
    Yang, Liang
    Zhou, Yongying
    Chen, Ping
    Guo, Yuming
    Zeng, Guang
    Disanto, Michael E.
    Hu, Weidong
    Zhang, Xinhua
    ISCIENCE, 2024, 27 (12)
  • [43] Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways
    Velagapudi, Srividya
    Wang, Dongdong
    Poti, Francesco
    Feuerborn, Renata
    Robert, Jerome
    Schlumpf, Eveline
    Yalcinkaya, Mustafa
    Panteloglou, Grigorios
    Potapenko, Anton
    Simoni, Manuela
    Rohrer, Lucia
    Nofer, Jerzy-Roch
    von Eckardstein, Arnold
    CARDIOVASCULAR RESEARCH, 2024, 120 (05) : 476 - 489
  • [44] Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage
    Harangi, M
    Seres, I
    Varga, Z
    Emri, G
    Szilvássy, Z
    Paragh, G
    Remenyik, É
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 60 (10) : 685 - 691
  • [45] Diminished Antioxidant Activity of High-Density Lipoprotein-Associated Proteins in Systolic Heart Failure
    Tang, W. H. Wilson
    Wu, Yuping
    Mann, Shirley
    Pepoy, Michael
    Shrestha, Kevin
    Borowski, Allen G.
    Hazen, Stanley L.
    CIRCULATION-HEART FAILURE, 2011, 4 (01) : 59 - 64
  • [46] MONITORING OF HIGH-DENSITY LIPOPROTEIN-ASSOCIATED AMYLOID A PROTEIN AFTER LIVER-TRANSPLANTATION
    MAURY, CPJ
    HOCKERSTEDT, K
    LAUTENSCHLAGER, I
    SCHEININ, TM
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (05) : 3825 - 3826
  • [47] Diminished Antioxidant Activity of High-Density Lipoprotein-Associated Proteins in Chronic Kidney Disease
    Kennedy, David J.
    Tang, W. H. Wilson
    Fan, Yiying
    Wu, Yuping
    Mann, Shirley
    Pepoy, Michael
    Hazen, Stanley L.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (02):
  • [48] Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage
    Mariann Harangi
    Ildikó Seres
    Zsuzsa Varga
    Gabriella Emri
    Zoltán Szilvássy
    György Paragh
    Éva Remenyik
    European Journal of Clinical Pharmacology, 2004, 60 : 685 - 691
  • [49] Enhancement of high-density lipoprotein-associated protease inhibitor activity prevents atherosclerosis progression
    Mobilia, Maura
    Karakashian, Alexander
    Neupane, Khaga R.
    Hage, Olivia
    Whitus, Callie
    Carter, Abigail
    Voy, Clairity
    Johnson, Lance A.
    Graf, Gregory A.
    Gordon, Scott M.
    ATHEROSCLEROSIS, 2024, 396
  • [50] Sphingosine kinases, sphingosine-1-phosphate and sphingolipidomics
    Maceyka, M
    Milstien, S
    Spiegel, S
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2005, 77 (1-4) : 15 - 22